318 related articles for article (PubMed ID: 1250540)
41. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
42. Differences in current clinical features of diploid and triploid hydatidiform mole.
Niemann I; Petersen LK; Hansen ES; Sunde L
BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
[TBL] [Abstract][Full Text] [Related]
43. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
44. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
45. [Comparative study of the HCS (Human Chorionic Somatomammotropin) level in maternal serum by radioimmunoassay and immunde diffusion].
Doszpod J; Kereszti J; Szigetvári I; Hadnagy J; Egyed J; Cseh I; Gáti I
Orv Hetil; 1976 Apr; 117(14):847-8. PubMed ID: 815866
[No Abstract] [Full Text] [Related]
46. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
47. Plasma levels of human chorionic somatomammotrophin, progesterone, unconjugated oestradiol and oestriol, and alpha-foetoprotein in patients with hydatidiform moles.
Miyakawa I; Yagi K; Nakayama M; Matsuo I; Maeyama M
J Endocrinol; 1977 Mar; 72(3):371-8. PubMed ID: 67163
[TBL] [Abstract][Full Text] [Related]
48. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction.
Lytras A; Bock ME; Dodd JG; Cattini PA
Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000
[TBL] [Abstract][Full Text] [Related]
49. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
50. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
51. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
Boyko WL; Russell HT
Obstet Gynecol; 1979 Dec; 54(6):737-45. PubMed ID: 514561
[TBL] [Abstract][Full Text] [Related]
52. Daily rhythm of serum human chorionic gonadotropin and human chorionic somatomammotropin in normal pregnancy.
Ayala AR; Bustos H; Aguilar RM
Int J Gynaecol Obstet; 1984 Jun; 22(3):173-6. PubMed ID: 6148272
[TBL] [Abstract][Full Text] [Related]
53. Radioimmunoassay of hCG as an early diagnosis of cerebral metastases in choriocarcinoma patients.
Soma H; Takayama M; Tokoro K; Kikuchi T; Kikuchi K; Saegusa H
Acta Obstet Gynecol Scand; 1980; 59(5):445-8. PubMed ID: 7446011
[TBL] [Abstract][Full Text] [Related]
54. [HCG in patients with hydatidiform mole or chorionepithelioma].
Rjosk HK; Gokel JM; Holzmann K
Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
[No Abstract] [Full Text] [Related]
55. Study on the systematic use of serial estimation of human placental lactogen (hPL) and human chorionic gonadotropin (hCG) for the management of trophoblastic neoplasia.
Chough SY
Endocrinol Jpn; 1973 Feb; 20(1):9-21. PubMed ID: 4353253
[No Abstract] [Full Text] [Related]
56. Comparison of the methods for measuring human chorionic gonadotrophin after hydatidiform mole.
Salmon JA; Peh KL; Ratnam SS
Acta Endocrinol (Copenh); 1976 Mar; 81(3):605-15. PubMed ID: 946350
[TBL] [Abstract][Full Text] [Related]
57. Primary pulmonary choriocarcinoma after human chorionic gonadotropin normalization following hydatidiform mole: a report of two cases.
Maestá I; Leite FV; Michelin OC; Rogatto SR
J Reprod Med; 2010; 55(7-8):311-6. PubMed ID: 20795344
[TBL] [Abstract][Full Text] [Related]
58. [The maternal and fetal levels of human chorionic gonadotropin, human placental lactogen and prolactin during the perinatal period (author's transl)].
Dericks-Tan JS; Baumann R
Geburtshilfe Frauenheilkd; 1976 Oct; 36(10):845-51. PubMed ID: 992299
[TBL] [Abstract][Full Text] [Related]
59. [Human placental lactogen and chorionic gonadotropin in diabetic pregnancies (author's transl)].
Artner J; Baumung H; Ogris E
Wien Klin Wochenschr; 1977 Aug; 89(15):524-31. PubMed ID: 899030
[TBL] [Abstract][Full Text] [Related]
60. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
Goldstein DP
Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
